同和药业：富马酸伏诺拉生原料药通过CDE审批

Core Viewpoint - The company Tonghe Pharmaceutical has received approval from the National Medical Products Administration (NMPA) for its active pharmaceutical ingredient, Fumaric Acid Venlafaxine, which is primarily used for the treatment of gastroesophageal reflux disease [1] Group 1 - The approval was obtained through the CDE's "Raw and Auxiliary Material Registration Information Publicity" platform [1] - Fumaric Acid Venlafaxine is indicated for the treatment of reflux esophagitis [1]